Literature DB >> 21652037

Preparative separation of lithospermic acid B from Salvia miltiorrhiza by polyamide resin and preparative high-performance liquid chromatography.

Y X Guo1, L L Zhou, T Li, L H Wang.   

Abstract

Adsorption on polyamide resin was investigated as a means of separating lithospermic acid B (LAB) from a crude extract of the roots of the traditional Chinese medicine Salvia miltiorrhiza Bunge ("Danshen"). Variables affecting adsorption capacity (solution pH, contact time on resin, initial LAB concentration) were studied. Adsorption was strongly dependent upon the initial concentration of LAB and pH. In all conditions, the polyamide resin gave optimal adsorption of LAB at an initial concentration of 2.66 mg/mL and pH <3.0. The adsorption isotherm correlated well with the Langmuir-type adsorption isotherm. Maximal adsorption capacity was calculated to be 380 mg/g at pH 2.0 and 25°C. LAB purity of 85.30% could be obtained by polyamide resin adsorption followed by elution with 70% ethanol solution, and the recovery was 87.1%. After preparative HPLC, the maximum HPLC purity obtained was 99.28% with a recovery of 75.2%. This method provides an efficient and low-cost method for LAB purification for industrial applications.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21652037     DOI: 10.1016/j.chroma.2011.05.048

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.601


  2 in total

1.  Promotion of quality standard of herbal medicine by constituent removing and adding.

Authors:  Dan Yan; Junxian Li; Yin Xiong; Congen Zhang; Jiaoyang Luo; Yumei Han; Ruiling Wang; Cheng Jin; Hong Qian; Jiangyu Li; Lingling Qiu; Cheng Peng; Yuling Lin; Xueai Song; Xiaohe Xiao
Journal:  Sci Rep       Date:  2014-01-13       Impact factor: 4.379

2.  Anticancer Effects of Salvia miltiorrhiza Alcohol Extract on Oral Squamous Carcinoma Cells.

Authors:  Wen-Hung Wang; Kuo-Yu Hsuan; Ling-Ya Chu; Chia-Ying Lee; Yu-Chang Tyan; Zong-Shiow Chen; Wan-Chi Tsai
Journal:  Evid Based Complement Alternat Med       Date:  2017-01-29       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.